ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
L01XG02 | B | Carfilzomib - 60mg | 8499/388 | 150015/1 | KYPROLIS | 60mg | 1 | Injectable powder for solution | Infusion | Mersaco | Amgen Technology (Ireland) Unlimited Company (ADL) | Ireland | L.L | 2.44 | E2 | Onyx Pharmaceuticals Inc | USA | 05/02/20 |
ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
L01XG02 | B | Carfilzomib - 60mg | 8499 | 150015/1 | KYPROLIS | 60mg | 1 | Injectable powder for solution | Infusion | Mersaco | Amgen Technology (Ireland) Unlimited Company (ADL) | Ireland | 96,642,005 L.L | 2.44 | E2 | Onyx Pharmaceuticals Inc | USA | 12/12/20 | 0 |